Cargando…
mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils
Autores principales: | Rubin-Bejerano, Ifat, Sansal-Castellano, Isabelle, Carlson, Mark, Reznik, Gabriel, Siedlecki, James, Kane, John, Dostalova, Zuzana, Miao, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292566/ http://dx.doi.org/10.1186/2051-1426-2-S3-P262 |
Ejemplares similares
-
The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
por: Sansal-Castellano, Isabelle, et al.
Publicado: (2015) -
xCITED2 Induces Neural Genes in Animal Cap Explants of Xenopus Embryos
por: Yoon, Jaeho, et al.
Publicado: (2011) -
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
por: Ralph, Stephen John, et al.
Publicado: (2022) -
Neutrophil Recruitment in Pneumococcal Pneumonia
por: Palmer, Catherine S., et al.
Publicado: (2022) -
Neutrophil DREAM promotes neutrophil recruitment in vascular inflammation
por: Li, Jing, et al.
Publicado: (2021)